Show simple item record

dc.contributor.authorPfaff, JA
dc.contributor.authorBendszus, M
dc.contributor.authorDonnan, G
dc.contributor.authorMolina, C
dc.contributor.authorLeys, D
dc.contributor.authorSchellinger, PD
dc.contributor.authorSchwab, S
dc.contributor.authorToni, D
dc.contributor.authorWahlgren, N
dc.contributor.authorHacke, W
dc.contributor.authorRingleb, PA
dc.date.accessioned2020-12-14T06:24:44Z
dc.date.available2020-12-14T06:24:44Z
dc.date.issued2020-12
dc.identifierpii: 10.1177_2396987320920114
dc.identifier.citationPfaff, J. A., Bendszus, M., Donnan, G., Molina, C., Leys, D., Schellinger, P. D., Schwab, S., Toni, D., Wahlgren, N., Hacke, W. & Ringleb, P. A. (2020). The impact of the DWI-FLAIR-mismatch in the ECASS-4 trial - A post hoc analysis.. Eur Stroke J, 5 (4), pp.370-373. https://doi.org/10.1177/2396987320920114.
dc.identifier.issn2396-9873
dc.identifier.urihttp://hdl.handle.net/11343/254210
dc.description.abstractIntroduction: To investigate the impact of a mismatch between diffusion-weighted imaging (DWI) and fluid attenuated inversion recovery (FLAIR) on functional outcome in patients with acute stroke in a prolonged time window or unknown time of symptom onset randomized to intravenous thrombolysis or placebo. Patients and Methods: We performed a post-hoc analysis of the European Cooperative Acute Stroke Study-4 (ECASS-4) trial. ECASS-4 was an investigator driven, phase 3, multi-center, double-blind, placebo-controlled study which randomized ischemic stroke patients presenting within 4.5 and 9h of stroke onset or unknown time-window to either rt-PA or placebo after MR-imaging. Two subgroups "no mismatch" (nMM) and "any mismatch" (aMM) were created by applying a DWI-FLAIR-mismatch criterion. We calculated frequency of nMM and aMM and performed a univariate analysis (Fisher's Test) for excellent clinical outcome (mRS 0-1) and mortality (mRS=6). Results: MR-Imaging of n=111/119 (93.2%) patients was suitable for this analysis. DWI-FLAIR mismatch was found in 49 patients (44.1%). Proportions of mismatch nMM and aMM were comparable in treatment-groups (aMM: Placebo 46.3%, Alteplase 42.1%; p=0.70). Patients with nMM showed no benefit of rt-PA-treatment (OR (95%CI) mRS 0-1: 0.95 (0.29-3.17)). Patients with aMM showed a point estimate of the odds ratio in favour of a treatment benefit of rt-PA (mRS 0-1: OR (95%CI) 2.62 (0.68-11.1)). Mortality within 90 days was not different in patients treated with rt-PA if nMM (15.2%) or aMM (12.5%) was present. Discussion: In this analysis no significant evidence, but subtle indication towards patients treated with rt-PA in a prolonged time window reaching an excellent clinical outcome if a DWI-FLAIR-mismatch is present on initial stroke MR-imaging. Conclusion: A DWI-FLAIR mismatch in the region of ischemia as imaging based surrogate parameter for patient selection for i.v. rt-PA should be strongly pursued.
dc.languageeng
dc.publisherSAGE Publications
dc.titleThe impact of the DWI-FLAIR-mismatch in the ECASS-4 trial - A post hoc analysis.
dc.typeJournal Article
dc.identifier.doi10.1177/2396987320920114
melbourne.affiliation.departmentMedicine (RMH)
melbourne.affiliation.facultyMedicine, Dentistry & Health Sciences
melbourne.source.titleEuropean Stroke Journal
melbourne.source.volume5
melbourne.source.issue4
melbourne.source.pages370-373
melbourne.elementsid1448715
melbourne.openaccess.urlhttp://doi.org/10.1177/2396987320920114
melbourne.openaccess.pmchttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856579
melbourne.openaccess.statusPublished version
melbourne.contributor.authorDonnan, Geoffrey
dc.identifier.eissn2396-9881
melbourne.accessrightsAccess this item via the Open Access location


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record